Sustained Therapeutics is a clinical stage company developing a drug delivery platform technology initially focused on non-opioid pain medication, but extendable to other APIs including significant oncology indications.

We recently announced the successful completion of the Phase 2 trial of our non-opioid medication for chronic pain. The study met both its primary and secondary endpoints and showed a month's pain relief from a single injection. The Phase 3 trial is now being planned.

We also have the pivotal Phase 2/3 trial of our sustained release hemotherapy medication underway in Upper Tract Urothelial Carcinoma. Our third product, for erectile dysfunction, is about to its Phase 2 trial.